NEURIM PHARMACEUTICALS (1991) LTD诉GENERICS UK LTD (T/A MYLAN)

Reports of Patent, Design and Trade Mark Cases Pub Date : 2021-04-01 DOI:10.1093/rpc/rcac004

{"title":"NEURIM PHARMACEUTICALS (1991) LTD诉GENERICS UK LTD (T/A MYLAN)","authors":"","doi":"10.1093/rpc/rcac004","DOIUrl":null,"url":null,"abstract":"\n H1 Patents — European patents — Pharmaceuticals — Interim injunctions — Proposed generic launch — Expedited trial — Assessment of adequacy of damages — Balance of convenience — Clearing the path — Appeal to Court of Appeal","PeriodicalId":336842,"journal":{"name":"Reports of Patent, Design and Trade Mark Cases","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"NEURIM PHARMACEUTICALS (1991) LTD v GENERICS UK LTD (T/A MYLAN)\",\"authors\":\"\",\"doi\":\"10.1093/rpc/rcac004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n H1 Patents — European patents — Pharmaceuticals — Interim injunctions — Proposed generic launch — Expedited trial — Assessment of adequacy of damages — Balance of convenience — Clearing the path — Appeal to Court of Appeal\",\"PeriodicalId\":336842,\"journal\":{\"name\":\"Reports of Patent, Design and Trade Mark Cases\",\"volume\":\"32 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Patent, Design and Trade Mark Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/rpc/rcac004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Patent, Design and Trade Mark Cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rpc/rcac004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

H1专利-欧洲专利-药品-临时禁令-拟议的仿制药上市-加速审判-损害赔偿充分性评估-便利平衡-扫清道路-上诉法院

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

NEURIM PHARMACEUTICALS (1991) LTD v GENERICS UK LTD (T/A MYLAN)

H1 Patents — European patents — Pharmaceuticals — Interim injunctions — Proposed generic launch — Expedited trial — Assessment of adequacy of damages — Balance of convenience — Clearing the path — Appeal to Court of Appeal

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Reports of Patent, Design and Trade Mark Cases

自引率

0.00%

发文量